Patients suffering from Parkinson’s disease who have faulty mitochondria may be able to see an improvement in their symptoms, through the use of niacin (vitamin B3). New findings show patients with early onset Parkinson’s disease may benefit from boosting their niacin, in certain forms of the disease that are inherited and involve faulty mitochondria.
Key Takeaways:
“The results of the study, which is funded by the Medical Research Council, reveal a mechanism for how early-onset Parkinson’s affects the brain, and point to other drugs that may also help this subset of patients.”
https://www.sciencedaily.com/releases/2017/01/170110092059.htm